204 related articles for article (PubMed ID: 26018798)
21. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
22. Primary chemotherapy for children with rhabdomyosarcoma of the 'special pelvic' sites: is preservation of the bladder possible?
Kamii Y; Taguchi N; Tsunematsu Y; Kakizawa Y; Saeki M; Honna T; Nakano M; Hashizume K; Komuro H; Bessho F
J Pediatr Surg; 1994 Mar; 29(3):461-4. PubMed ID: 8201521
[TBL] [Abstract][Full Text] [Related]
23. [Sarcoma botryoides (embryonal rhabdomyosarcoma) as an unusual diagnosis of cervix polyps].
Kaserer K; Kainz C; Reinthaller A; Amann G; Beer F; Breitenecker G
Pathologe; 1995 Jul; 16(4):287-91. PubMed ID: 7667212
[TBL] [Abstract][Full Text] [Related]
24. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
25. [Systemic therapy in children and adolescents].
Kremens B
Urologe A; 2007 Oct; 46(10):1404-6. PubMed ID: 17823786
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations.
Agaram NP; Huang SC; Tap WD; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2022 Mar; 61(3):131-137. PubMed ID: 34755412
[TBL] [Abstract][Full Text] [Related]
27. Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography.
Casey DL; Wexler LH; Fox JJ; Dharmarajan KV; Schoder H; Price AN; Wolden SL
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1136-42. PubMed ID: 25539372
[TBL] [Abstract][Full Text] [Related]
28. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
Douglas JG; Arndt CA; Hawkins DS
Eur J Cancer; 2007 Apr; 43(6):1045-50. PubMed ID: 17368885
[TBL] [Abstract][Full Text] [Related]
29. Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96.
Seitz G; Dantonello TM; Int-Veen C; Blumenstock G; Godzinski J; Klingebiel T; Schuck A; Leuschner I; Koscielniak E; Fuchs J;
Pediatr Blood Cancer; 2011 May; 56(5):718-24. PubMed ID: 21370402
[TBL] [Abstract][Full Text] [Related]
30. Long term survival in two children with rhabdomyosarcoma of the biliary tract.
Huber J; Sovinz P; Freidl T; Jahnel J; Lackner H; Höllwarth M; Otte JB; Urban C
Klin Padiatr; 2008; 220(6):378-9. PubMed ID: 18949674
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
[TBL] [Abstract][Full Text] [Related]
32. Embryonal rhabdomyosarcoma in adults.
Lloyd RV; Hajdu SI; Knapper WH
Cancer; 1983 Feb; 51(3):557-65. PubMed ID: 6821833
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
Lawrence W; Anderson JR; Gehan EA; Maurer H
Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
[TBL] [Abstract][Full Text] [Related]
34. [Genitourinary rhabdomyosarcoma in childhood].
González Rivero MA; Mulet JF; Martín JC; Illa J; Melo M; Pardo N; Turmo J; Vela E; Badía RM; Cubells J
Cir Pediatr; 1989 Oct; 2(4):186-90. PubMed ID: 2488079
[TBL] [Abstract][Full Text] [Related]
35. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.
Crist WM; Garnsey L; Beltangady MS; Gehan E; Ruymann F; Webber B; Hays DM; Wharam M; Maurer HM
J Clin Oncol; 1990 Mar; 8(3):443-52. PubMed ID: 2407808
[TBL] [Abstract][Full Text] [Related]
36. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
37. Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group.
Dantonello TM; Winkler P; Boelling T; Friedel G; Schmid I; Mattke AC; Ljungman G; Bielack SS; Klingebiel T; Koscielniak E;
Pediatr Blood Cancer; 2011 May; 56(5):725-32. PubMed ID: 21370403
[TBL] [Abstract][Full Text] [Related]
38. The effect of age at diagnosis on outcome in rhabdomyosarcoma.
La Quaglia MP; Heller G; Ghavimi F; Casper ES; Vlamis V; Hajdu S; Brennan MF
Cancer; 1994 Jan; 73(1):109-17. PubMed ID: 8275414
[TBL] [Abstract][Full Text] [Related]
39. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.
Gerber NK; Wexler LH; Singer S; Alektiar KM; Keohan ML; Shi W; Zhang Z; Wolden S
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):58-63. PubMed ID: 23414767
[TBL] [Abstract][Full Text] [Related]
40. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy.
Ladra MM; Mandeville HC; Niemierko A; Padera TP; Friedmann AM; MacDonald SM; Ebb D; Chen YL; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):358-67. PubMed ID: 25864172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
